APA (7th ed.) Citation

T, C., T, Z., U, E., N, P., C, F., A, P., . . . N, S. (2026). Complete remission of relapsed ATXN2L: :JAK2 fusion positive anaplastic large cell lymphoma following ruxolitinib monotherapy in a child. NPJ precision oncology, 10(1), . https://doi.org/10.1038/s41698-026-01299-z

Chicago Style (17th ed.) Citation

T, Cohen, et al. "Complete Remission of Relapsed ATXN2L: :JAK2 Fusion Positive Anaplastic Large Cell Lymphoma Following Ruxolitinib Monotherapy in a Child." NPJ Precision Oncology 10, no. 1 (2026). https://doi.org/10.1038/s41698-026-01299-z.

MLA (9th ed.) Citation

T, Cohen, et al. "Complete Remission of Relapsed ATXN2L: :JAK2 Fusion Positive Anaplastic Large Cell Lymphoma Following Ruxolitinib Monotherapy in a Child." NPJ Precision Oncology, vol. 10, no. 1, 2026, https://doi.org/10.1038/s41698-026-01299-z.